144 related articles for article (PubMed ID: 17551255)
1. BRCA1 germline mutation in a woman with metaplastic squamous cell breast cancer.
Breuer A; Kandel M; Fisseler-Eckhoff A; Sutter C; Schwaab E; Lück HJ; du Bois A
Onkologie; 2007 Jun; 30(6):316-8. PubMed ID: 17551255
[TBL] [Abstract][Full Text] [Related]
2. Low-grade adenosquamous carcinoma of the breast--A case report with a BRCA1 germline mutation.
Noël JC; Buxant F; Engohan-Aloghe C
Pathol Res Pract; 2010 Jul; 206(7):511-3. PubMed ID: 20189727
[TBL] [Abstract][Full Text] [Related]
3. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
[TBL] [Abstract][Full Text] [Related]
4. A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinoma.
Rashid MU; Shah MA; Azhar R; Syed AA; Amin A; Hamann U
Pathol Res Pract; 2011 Sep; 207(9):583-6. PubMed ID: 21723046
[TBL] [Abstract][Full Text] [Related]
5. First description of a sporadic breast cancer in a woman with BRCA1 germline mutation.
Curtit E; Benhamo V; Gruel N; Popova T; Manie E; Cottu P; Mariani O; Stoppa-Lyonnet D; Pivot X; Stern MH; Vincent-Salomon A
Oncotarget; 2015 Nov; 6(34):35616-24. PubMed ID: 26426992
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients.
Noh JM; Choi DH; Nam SJ; Lee JE; Kim JW; Kim SW; Kang E; Lee MH; Ahn SH; Kim KS; Park SK; Haffty BG;
Breast Cancer Res Treat; 2012 Jan; 131(1):217-22. PubMed ID: 21847643
[TBL] [Abstract][Full Text] [Related]
7. Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status.
Fourquet A; Stoppa-Lyonnet D; Kirova YM; Sigal-Zafrani B; Asselain B; ;
Am J Clin Oncol; 2009 Apr; 32(2):127-31. PubMed ID: 19307946
[TBL] [Abstract][Full Text] [Related]
8. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
9. High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
Sanford RA; Song J; Gutierrez-Barrera AM; Profato J; Woodson A; Litton JK; Bedrosian I; Albarracin CT; Valero V; Arun B
Cancer; 2015 Oct; 121(19):3422-7. PubMed ID: 26280679
[TBL] [Abstract][Full Text] [Related]
10. First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report.
Ripamonti CB; Colombo M; Mondini P; Siranoush M; Peissel B; Bernard L; Radice P; Carcangiu ML
BMC Cancer; 2013 Feb; 13():46. PubMed ID: 23374397
[TBL] [Abstract][Full Text] [Related]
11. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
[TBL] [Abstract][Full Text] [Related]
12. Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review.
Yamashita M; Kamei Y; Murakami A; Ozaki E; Okujima K; Takemoto K; Takaoka M; Tsukamoto D; Kusakabe E; Shidahara T; Noda H; Aoki R; Taguchi K; Nishiyama K; Eguchi M; Takada Y
Hered Cancer Clin Pract; 2021 Jan; 19(1):3. PubMed ID: 33407746
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation.
El Tannouri R; Albuisson E; Jonveaux P; Luporsi E
Fam Cancer; 2019 Jan; 18(1):1-8. PubMed ID: 29550896
[TBL] [Abstract][Full Text] [Related]
14. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
[TBL] [Abstract][Full Text] [Related]
16. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
[TBL] [Abstract][Full Text] [Related]
17. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 germline mutation and glioblastoma development: report of cases.
Boukerroucha M; Josse C; Segers K; El-Guendi S; Frères P; Jerusalem G; Bours V
BMC Cancer; 2015 Mar; 15():181. PubMed ID: 25880076
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
Fostira F; Tsitlaidou M; Papadimitriou C; Pertesi M; Timotheadou E; Stavropoulou AV; Glentis S; Bournakis E; Bobos M; Pectasides D; Papakostas P; Pentheroudakis G; Gogas H; Skarlos P; Samantas E; Bafaloukos D; Kosmidis PA; Koutras A; Yannoukakos D; Konstantopoulou I; Fountzilas G
Breast Cancer Res Treat; 2012 Jul; 134(1):353-62. PubMed ID: 22434525
[TBL] [Abstract][Full Text] [Related]
20. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.
Vaziri SA; Krumroy LM; Elson P; Budd GT; Darlington G; Myles J; Tubbs RR; Casey G
Clin Cancer Res; 2001 Jul; 7(7):1937-45. PubMed ID: 11448907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
